ERBB2 and breast cancer: Conversely, the non-enhancing breast cancer lesions were not associated with any prognostic factor, such as status of ER and/or PR, HER2 expression and/or amplification, and percentage of Ki67, which might be associated with the probability of showing enhancement (25).